ICER Report: Price Hikes for Eight Drugs Lead to $1.3 Billion Increase in U.S. Healthcare Costs
The Institute for Clinical and Economic Review (ICER) reported that price increases for eight drugs led [...]
Revolutionizing Healthcare: Epic and Elevance Health’s Data-Driven, AI-Enhanced Collaboration
The healthcare technology sector is experiencing significant advancements due to the efforts of two major players: [...]
FTC Challenges Sanofi’s Deal for Pompe Disease Treatment, Citing Monopoly Concerns
The Federal Trade Commission (FTC) is challenging Sanofi’s proposed $755 million deal to license Maze Therapeutics’ [...]
FDA Approves Groundbreaking CRISPR Gene-Editing Medicine for Sickle Cell Disease
The FDA has approved the world's first CRISPR gene-editing medicine, Casgevy, for sickle cell disease, marking [...]
Advancements and Challenges in GLP-1 Based Therapies for Diabetes and Obesity
In January 2010, the FDA approved Novo Nordisk's Victoza (liraglutide), a GLP-1 receptor agonist for Type [...]
Implementing Diversity Action Plans in Clinical Trials: Navigating FDA Requirements and Enhancing Inclusivity
In April 2022, the FDA mandated that all Phase 3 and pivotal studies include a Diversity [...]
Global Angiography Catheter Market: Surge in Demand Driven by Minimally Invasive Procedures and Cardiovascular Disease Prevalence
The global angiography catheter market, valued at $1.57 billion in 2024, is expected to grow at [...]
AbbVie Expands Neuroscience Portfolio with $8.7 Billion Acquisition of Cerevel Therapeutics
AbbVie has announced plans to acquire Cerevel Therapeutics, a neuroscience drugmaker, for $8.7 billion, marking its [...]
FDA Gives First Approval for Novartis’ Iptacopan, a Revolutionary Oral Treatment for Rare Blood Disorder PNH
Novartis has received FDA approval for iptacopan, an innovative oral treatment for paroxysmal nocturnal hemoglobinuria (PNH), [...]
Exploring the Potential and Challenges of mRNA Technology in Revolutionizing Flu Vaccines
The article discusses the potential of mRNA technology, popularized during the COVID-19 pandemic, in revolutionizing flu [...]
Navigating Pharmaceutical Sales with Next Best Action 2.0: A Data-Driven Approach
In the ever-evolving pharmaceutical business, the Next Best Action (NBA) approach has emerged as a crucial [...]
Consolidation of US Hospitals Leads to Increased Profits but Not Improved Care Quality, Study Finds
The consolidation of US hospitals increased between 2000 and 2020, with multi-unit hospital systems now owning [...]
UK Biobank Releases Groundbreaking Dataset from Whole Genome Sequencing of 500,000 Participants, Poised to Transform Medical Research
UK Biobank has unveiled a comprehensive dataset from genome sequencing of 500,000 participants, marking a milestone [...]
Samsung Bioepis Set to Launch Stelara Biosimilar in 2025 Amid Challenges for Medicare Price Negotiation Exemption
Samsung Bioepis recently finalized an agreement allowing its Stelara biosimilar, SB17, to launch in February 2025. [...]
Trump Revives ACA Debate, Faces Pushback Amid Biden’s Healthcare Emphasis
Donald Trump has recently reignited the debate over the Affordable Care Act (ACA), also known as [...]
AbbVie Expands Oncology Footprint with $10.1 Billion Acquisition of ImmunoGen
AbbVie, a pharmaceutical giant, announced its plan to acquire ImmunoGen, a clinical-stage biotech company specializing in [...]
Balancing Public Health and Environmental Sustainability: Insights from the Unitaid Report
The recent Unitaid report highlights a complex issue in climate change: the significant environmental impact of [...]
Harvard Researchers Urge Removal of Single Orphan Drug Exemption in Inflation Reduction Act
Biopharma companies are protesting the Inflation Reduction Act's (IRA) pricing negotiations for drugs with multiple orphan [...]
Gilead Sciences’ Kite Pharma Announces Workforce Reduction and Strategy Shift Amid FDA Review
Gilead Sciences' Kite Pharma is reducing its workforce by approximately 7% as part of a business [...]
Pioneering the Path for FDA Approval of Gender-Affirming Hormone Therapies: The Research Institute for Gender Therapeutics’ Groundbreaking Initiative
The Research Institute for Gender Therapeutics (RIGT), a nonprofit organization, is pioneering research to gain FDA [...]
Merck’s Pneumococcal Vaccine V116 Matches Pfizer’s Prevnar 20 in Phase 3 Trial
Merck’s investigational pneumococcal vaccine V116 demonstrated efficacy and safety levels similar to Pfizer’s Prevnar 20 vaccine [...]
NIH Invests $9.7 Million in Research Projects Utilizing All of Us Program Data
The NIH awarded $9.7 million to 26 projects over two years to enhance research using the [...]
Truveta’s Comparative Study on Weight Loss Effectiveness of Semaglutide and Tirzepatide in Overweight and Obese Patients
Truveta's new research explored the effectiveness of semaglutide (Ozempic) and tirzepatide (Mounjaro) in weight loss among [...]
Nearly Half of Americans Affected by COVID-19 Misinformation, Study Finds
Almost half of Americans felt their decisions related to COVID-19 were influenced by misinformation, and 43.7% [...]
FDA Launches START Program to Accelerate Development of Therapies for Rare Diseases
The FDA has launched the Support for Clinical Trials Advancing Rare Disease Therapeutics (START) program, applying [...]